From: Review of light activated antibacterial nanomaterials in the second biological window
Feature | NIR-II Nanomaterials | Conventional Antibacterial Therapies |
---|---|---|
Mechanism of Action | Photothermal & Photodynamic effects | Antibiotics, antimicrobial peptides, disinfectants |
Target Specificity | Highly targeted with minimal collateral damage | Broad-spectrum, potential off-target effects |
Resistance Development | Lower likelihood of bacterial resistance | High due to overuse and misuse of antibiotics |
Tissue Penetration | Deep penetration due to NIR-II properties | Limited, especially in deep-seated infections |
Immune System Modulation | Can enhance immune response via antigen presentation | Some antibiotics may suppress immune function |
Microbiome Impact | Less disruption of commensal bacteria with targeted application | Often disrupts gut and skin microbiome, leading to dysbiosis |
Scalability and Cost | High cost and scalability challenges | Established production with varying costs |
Side Effects | Potential localized heating or oxidative stress | Allergic reactions, gut microbiome imbalance, organ toxicity |
Multi-functionality | Can integrate therapy, imaging, and diagnostics | Primarily treatment-focused |